Midday Nasdaq Down on Facebook (NASDAQ:FB), Peregrine Pharma (NASDAQ:PPHM)
By
Jonah Loeb Sep 24, 2012 3:25 pm
Apple also dips after riots in China.
MINYANVILLE ORIGINALThe Nasdaq Composite Index (INDEXNASDAQ:.IXIC) fell 0.47% to 3,164.61 at 3:00 p.m. today as doubts lingered about the eurozone debt crisis.
The tech sector was lagging, due in no small part to Apple (NASDAQ:AAPL), which fell 1.63% to $688.79 as investors bemoaned the tech giant’s inability to accommodate the massive demand for the iPhone 5; riots at a Chinese factory where the phones are assembled may also have played a part.
After Barron’s used its cover story this week to question Facebook's (NASDAQ:FB) mobile advertising business, the social networking company saw its stock fall 7.48% to $21.15 after making a decent recovery in recent weeks. One of the few bright spots was TiVo (NASDAQ:TIVO), which rose 4.29% to $9.97 after settling its lawsuit against Verizon (NASDAQ:VZ) for over $250 million.
Easily the biggest loser was Peregrine Pharmaceuticals (NASDAQ:PPHM), which dropped a staggering 76.62% to a mere $1.26 on 15 times its average volume after a crucial mistake marred the study on its new cancer drug. Questcor Pharmaceuticals (NASDAQ:QCOR) also didn’t have the best day, falling 34.88% to $19.62 on high volume after the federal government announced an investigation into Questcor’s promotional practices.
The tech sector was lagging, due in no small part to Apple (NASDAQ:AAPL), which fell 1.63% to $688.79 as investors bemoaned the tech giant’s inability to accommodate the massive demand for the iPhone 5; riots at a Chinese factory where the phones are assembled may also have played a part.
After Barron’s used its cover story this week to question Facebook's (NASDAQ:FB) mobile advertising business, the social networking company saw its stock fall 7.48% to $21.15 after making a decent recovery in recent weeks. One of the few bright spots was TiVo (NASDAQ:TIVO), which rose 4.29% to $9.97 after settling its lawsuit against Verizon (NASDAQ:VZ) for over $250 million.
Easily the biggest loser was Peregrine Pharmaceuticals (NASDAQ:PPHM), which dropped a staggering 76.62% to a mere $1.26 on 15 times its average volume after a crucial mistake marred the study on its new cancer drug. Questcor Pharmaceuticals (NASDAQ:QCOR) also didn’t have the best day, falling 34.88% to $19.62 on high volume after the federal government announced an investigation into Questcor’s promotional practices.
No positions in stocks mentioned.


Daily Recap
Everything you need to know for the next trading day.
Trading Radar (weekly)
Your road map to all the events that will effect financial markets in the week ahead.
Name
Email
*
Phone

* required field

business news
PRINT























